Literature DB >> 21969901

Visceral Leishmaniasis with an Unusual Presentation in an HIV Positive Patient.

Nazar M T Jawhar1.   

Abstract

Visceral leishmaniasis is a disease caused by a haemoflagellate protozoan of the genus Leishmania. It has a wide geographical spread. Classic cases are found primarily in children and present with typical features that include fever, anaemia, hepatosplenomegaly, hypergammaglobulinaemia, and pancytopenia. The diagnosis is usually achieved by bone marrow smears, culture and serology; however, it can manifest itself atypically, mostly in patients infected with HIV and geriatric immunocompetent patients. We report an unusual case of visceral leishmaniasis diagnosed in a 27 year-old HIV-infected male who presented with abdominal discomfort and diarrhoea of four weeks duration associated with nausea and vomiting, but with no typical symptoms or signs of visceral leishmaniasis. The diagnosis was established through the identification of the Leishmania organism in duodenal and colonic biopsies and confirmed by subsequent bone marrow smears.

Entities:  

Keywords:  Case report; Duodenal biopsy; HIV; Iraq; Visceral leishmaniasis

Year:  2011        PMID: 21969901      PMCID: PMC3121034     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  21 in total

1.  Leishmania/HIV co-infection. Epidemiological analysis of 692 retrospective cases.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1997-02-21

2.  [Visceral leishmaniasis in a patient with HIV-2 infection].

Authors:  R Sarmento e Castro; A A Horta; O Vasconcelos; H Coelho; C Granato; A Rocha Marques
Journal:  Rev Clin Esp       Date:  1995-08       Impact factor: 1.556

3.  Leishmaniasis or AIDS?

Authors:  A de la Loma; J Alvar; E Martinez Galiano; J Blázquez; A Alcalá Muñoz; R Nájera
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

4.  The histological spectrum of visceral leishmaniasis caused by Leishmania infantum MON-1 in acquired immune deficiency syndrome.

Authors:  V Hofman; P Marty; C Perrin; M C Saint-Paul; Y Le Fichoux; J F Michiels; N Glaichenhaus; F Pratlong; P Hofman
Journal:  Hum Pathol       Date:  2000-01       Impact factor: 3.466

5.  Duodenal leishmaniasis diagnosed by biopsy in two HIV-positive patients.

Authors:  M J Alonso; E Muñoz; A Picazo; M M Abad; F Gómez; M Roldán; F Laguna; J I Paz; A López-Bravo
Journal:  Pathol Res Pract       Date:  1997       Impact factor: 3.250

Review 6.  Leishmaniasis in HIV infection.

Authors:  R Paredes; J Munoz; I Diaz; P Domingo; M Gurgui; B Clotet
Journal:  J Postgrad Med       Date:  2003 Jan-Mar       Impact factor: 1.476

7.  Leishmaniasis and AIDS co-infection: the Spanish example.

Authors:  J Alvar
Journal:  Parasitol Today       Date:  1994-04

Review 8.  [Intestinal parasitic infections and leishmaniasis in patients with HIV infection].

Authors:  A Moreno-Camacho; R López-Vélez; A Muñoz Sanz; P Labarga-Echevarría
Journal:  Enferm Infecc Microbiol Clin       Date:  1998       Impact factor: 1.731

Review 9.  Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review.

Authors:  F Laguna; J García-Samaniego; V Soriano; E Valencia; C Redondo; M J Alonso; J M González-Lahoz
Journal:  Clin Infect Dis       Date:  1994-07       Impact factor: 9.079

Review 10.  Visceral Leishmaniasis presenting with intestinal failure: a case report and literature review.

Authors:  Lucy Hicks; Prashant Kant; Poi Hoon Tay; Veronica Vincini; Helmut Schuster; Olorunda Rotimi; Nicola Maughan; Christopher Jordan; Stephen Moss; Simon Everett; Peter John Hamlin
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-01       Impact factor: 2.566

View more
  1 in total

1.  Relapse of visceral leishmaniasis in an HIV-infected patient successfully treated with a combination of miltefosine and amphotericin B.

Authors:  Shauna McQuarrie; Ken Kasper; Dana C Moffatt; Daniel Marko; Yoav Keynan
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Nov-Dec       Impact factor: 2.471

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.